Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wedbush Maintains Underperform on Bed Bath & Beyond, Lowers Price Target to $0

Wedbush Maintains Underperform on Bed Bath & Beyond, Lowers Price Target to $0

Wedbush analyst Seth Basham maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Underperform and lowers the price target from $1 to $0.

February 7, 2023

1 minute read

Wedbush analyst Seth Basham maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Underperform and lowers the price target from $1 to $0.

Abbott Highlights Launch Of World’s Smallest Implantable, Rechargeable Spinal Cord Stimulation System For Chronic Pain

December 29, 10:14 AM

https://www.accesswire.com/733557/Abbott-Launches-the-Worlds-Smallest-Implantable-Rechargeable-Spinal-Cord-Stimulation-System-for-Chronic-Pain

November 10, 12:48 PM

Analysts have provided the following ratings for D.R. Horton (NYSE:DHI) within the last quarter:

May 31, 7:07 AM

Airlines are facing pressure on yields due to rising costs and increased competition.

October 17, 11:54 PM

Canadian workers union Unifor said on Tuesday that it will commence official negotiations with Chrysler-parent Stellantis NV (NYSE:STLA)…